Loading...
XSHG600436
Market cap18bUSD
Dec 20, Last price  
220.50CNY
1D
-0.26%
1Q
9.70%
Jan 2017
381.76%
Name

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600436 chart
P/E
47.56
P/S
13.33
EPS
4.64
Div Yield, %
0.57%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
15.92%
Revenues
10.06b
+15.69%
253,486,070418,820,927522,205,339593,069,218649,743,490694,749,846867,314,5831,021,565,7281,171,153,7381,395,868,5181,453,869,7711,885,674,6732,308,954,2693,713,953,9754,766,156,8935,722,273,4316,510,781,9578,021,550,4518,694,001,50410,058,497,338
Net income
2.80b
+13.15%
41,773,64986,398,28381,908,17595,188,986140,869,750129,663,236194,131,768254,867,961348,529,663429,768,408438,828,802466,676,722536,131,906807,018,6751,142,932,9171,374,376,8231,671,518,6672,431,899,9332,472,344,7312,797,351,515
CFO
2.21b
-67.89%
98,671,51669,055,60450,703,65460,038,07012,573,378129,519,043205,410,719232,950,354162,398,128274,336,209264,499,645305,510,311394,537,198676,933,316612,310,81801,467,076,541462,272,4046,873,030,5802,206,631,519
Dividend
Jun 07, 20242.32 CNY/sh

Profile

Zhangzhou Pientzehuang Pharmaceutical., Ltd engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. The company's products include medicines and health products, cosmetics, daily chemicals, medical apparatus and instruments, and health foods. The company is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical., Ltd is a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.
URL
https://www.zzpzh.com/
IPO date
Jun 16, 2003
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
10,058,497
15.69%
8,694,002
8.38%
8,021,550
23.20%
Cost of revenue
6,288,398
5,490,271
4,867,811
Unusual Expense (Income)
NOPBT
3,770,099
3,203,730
3,153,739
NOPBT Margin
37.48%
36.85%
39.32%
Operating Taxes
517,773
454,758
405,002
Tax Rate
13.73%
14.19%
12.84%
NOPAT
3,252,326
2,748,972
2,748,737
Net income
2,797,352
13.15%
2,472,345
1.66%
2,431,900
45.49%
Dividends
(784,638)
(730,014)
(542,985)
Dividend yield
0.54%
0.42%
0.21%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
989,932
1,000,172
798,546
Long-term debt
250,020
217,593
173,336
Deferred revenue
17,667
17,010
20,243
Other long-term liabilities
86,390
82,825
65,110
Net debt
(9,565,034)
(1,975,491)
(6,924,822)
Cash flow
Cash from operating activities
2,206,632
6,873,031
462,272
CAPEX
(141,873)
Cash from investing activities
(2,798,612)
78,286
Cash from financing activities
(768,919)
FCF
8,402,017
(3,826,403)
2,479,047
Balance
Cash
10,173,010
2,496,426
7,105,626
Long term investments
631,976
696,830
791,078
Excess cash
10,302,061
2,758,556
7,495,627
Stockholders' equity
11,219,866
10,777,845
9,098,380
Invested Capital
4,855,157
10,166,352
3,475,614
ROIC
43.30%
40.30%
83.35%
ROCE
24.82%
24.67%
28.62%
EV
Common stock shares outstanding
602,877
603,317
603,317
Price
241.99
-16.11%
288.46
-34.01%
437.15
63.41%
Market cap
145,890,322
-16.17%
174,032,882
-34.01%
263,740,118
63.41%
EV
136,869,460
172,551,364
257,247,034
EBITDA
3,898,798
3,284,088
3,287,231
EV/EBITDA
35.11
52.54
78.26
Interest
37,307
38,007
32,898
Interest/NOPBT
0.99%
1.19%
1.04%